Erythromycin is More Effective than Metoclopramide in the Treatment of Feed Intolerance in Critical Illness

@inproceedings{Janossy2008ErythromycinIM,
  title={Erythromycin is More Effective than Metoclopramide in the Treatment of Feed Intolerance in Critical Illness},
  author={Kate Janossy and Chris Cairns and Bruce Raymond Taylor},
  year={2008}
}
In intensive care patients with feed intolerance, erythromycin reduces gastric residual volume more effectively than metoclopramide (NNT 4). Both drugs rapidly become ineffective. In patients who fail monotherapy, an open-label, non-controlled extension of this study suggests combination therapy may be effective.Level of evidence: 1+ (RCT with a low risk of bias) 

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 60 CITATIONS, ESTIMATED 34% COVERAGE

[Promotility drugs use in critical care: indications and limits?].

  • Annales francaises d'anesthesie et de reanimation
  • 2009
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Prokinetic therapy for feed intolerance in critical illness: one drug or two?

  • Critical care medicine
  • 2007
VIEW 10 EXCERPTS
CITES METHODS, BACKGROUND & RESULTS
HIGHLY INFLUENCED

Gastrointestinal dysmotility in critically ill patients

  • Annals of gastroenterology
  • 2018
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2007
2019

CITATION STATISTICS

  • 11 Highly Influenced Citations